FDA Rips Apotex's 'Utterly Misguided' Inspection Response
The U.S. Food and Drug Administration on Tuesday released a blistering warning letter accusing Apotex Inc. of serious manufacturing violations at a plant in India, adding to doubts about data integrity...To view the full article, register now.
Already a subscriber? Click here to view full article